The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments

被引:425
|
作者
Mahnke, K
Guo, M
Lee, S
Sepulveda, H
Swain, SL
Nussenzweig, M
Steinman, RM
机构
[1] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA
[2] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA
[3] Trudeau Inst Inc, Saranac Lake, NY 12983 USA
来源
JOURNAL OF CELL BIOLOGY | 2000年 / 151卷 / 03期
关键词
dendritic cell; antigen presentation; DEC-205; MHC class II; endocytosis;
D O I
10.1083/jcb.151.3.673
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Many receptors for endocytosis recycle into and out of cells through early endosomes. We now find in dendritic cells that the DEC-205 multilectin receptor targets late endosomes or lysosomes rich in major histocompatibility complex class II (MHC II) products, whereas the homologous macrophage mannose receptor (MMR), as expected, is found in more peripheral endosomes. To analyze this finding, the cytosolic tails of DEC-205 and MMR were fused to the external domain of the CD16 Fc gamma receptor and studied in stable L cell transfectants. The two cytosolic domains each mediated rapid uptake of human immunoglobulin (Ig)G followed by recycling of intact CD16 to the cell surface. However, the DEC-205 tail recycled the CD16 through MHC II-positive late endosomal/lysosomal vacuoles and also mediated a 100-fold increase in antigen presentation. The mechanism of late endosomal targeting, which occurred in the absence of human IgG, involved two functional regions: a membrane-proximal region with a coated pit sequence for uptake, and a distal region with an EDE triad for the unusual deeper targeting, Therefore, the DEC-205 cytosolic domain mediates a new pathway of receptor-mediated endocytosis that entails efficient recycling through late endosomes and a greatly enhanced efficiency of antigen presentation to CD4(+) T cells.
引用
收藏
页码:673 / 683
页数:11
相关论文
共 50 条
  • [21] Selective modulation of the major histocompatibility complex class II antigen presentation pathway following B cell receptor ligation and protein kinase C activation
    Barois, N
    Forquet, F
    Davoust, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (06) : 3641 - 3647
  • [22] Antigen-B Cell Receptor Complexes Associate with Intracellular major histocompatibility complex (MHC) Class II Molecules
    Barroso, Margarida
    Tucker, Heidi
    Drake, Lisa
    Nichol, Kathleen
    Drake, James R.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (45) : 27101 - 27112
  • [23] Disruption of Multivesicular Body Vesicles Does Not Affect Major Histocompatibility Complex (MHC) Class II-Peptide Complex Formation and Antigen Presentation by Dendritic Cells
    Bosch, Berta
    Berger, Adam C.
    Khandelwal, Sanjay
    Heipertz, Erica L.
    Scharf, Brian
    Santambrogio, Laura
    Roche, Paul A.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (34) : 24286 - 24292
  • [24] Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II
    Rehm, Kristina E.
    Connor, Ramsey F.
    Jones, Gwendolyn J. B.
    Yimbu, Kenneth
    Mannie, Mark D.
    Roper, Rachel L.
    [J]. IMMUNOLOGY, 2009, 128 (03) : 381 - 392
  • [25] Helminth Antigen-Conditioned Dendritic Cells Generate Anti-Inflammatory Cd4 T Cells Independent of Antigen Presentation via Major Histocompatibility Complex Class II
    Matisz, Chelsea E.
    Geuking, Markus B.
    Lopes, Fernando
    Petri, Bjorn
    Wang, Arthur
    Sharkey, Keith A.
    McKay, Derek M.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2018, 188 (11): : 2589 - 2604
  • [26] Ryanodine Receptor Activation by Cav1.2 Is Involved in Dendritic Cell Major Histocompatibility Complex Class II Surface Expression
    Vukcevic, Mirko
    Spagnoli, Giulio C.
    Iezzi, Giandomenica
    Zorzato, Francesco
    Treves, Susan
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (50) : 34913 - 34922
  • [27] Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation
    Delamarre, L
    Holcombe, H
    Mellman, I
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01): : 111 - 122
  • [28] Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts
    Liu, Y
    Hamrah, P
    Zhang, Q
    Taylor, AW
    Dana, MR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (02): : 259 - 268
  • [29] MODULATION OF ANTIGEN-PROCESSING BY BOUND ANTIBODIES CAN BOOST OR SUPPRESS CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX PRESENTATION OF DIFFERENT T-CELL DETERMINANTS
    SIMITSEK, PD
    CAMPBELL, DG
    LANZAVECCHIA, A
    FAIRWEATHER, N
    WATTS, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06): : 1957 - 1963
  • [30] Syk tyrosine kinase and B cell antigen receptor (BCR) immunoglobulin-α subunit determine BCR-mediated major histocompatibility complex class II restricted antigen presentation
    Lankar, D
    Briken, V
    Adler, K
    Weiser, P
    Cassard, S
    Blank, U
    Viguier, M
    Bonnerot, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (05): : 819 - 831